Table 5

Clinical Outcomes at 9 Months

VariableTriple (n = 200)Standard (n = 200)p Value
Death1 (0.5%)00.999
 Cardiac1 (0.5%)0
 Noncardiac00
MI1 (0.5%)1 (0.5%)0.999
 Q-wave1 (0.5%)0
 Non–Q-wave01 (0.5%)
TLR5 (2.5%)14 (7.0%)0.034
 Drug-eluting stent1 (0.5%)10 (5%)
 Cutting balloon2 (1%)2 (1%)
 Bypass surgery2 (1%)2 (1%)
Stent thrombosis01 (0.5%)0.999
 Acute01 (0.5%)
 Subacute00
 Late00
TVR7 (3.5%)16 (8.0%)0.053
Death/MI/TVR8 (4.0%)16 (8.0%)0.092
MACE6 (3.0%)14 (7.0%)0.066

MACE = major adverse cardiac events including death, myocardial infarction, and target lesion revascularization; MI = myocardial infarction; TLR = target lesion revascularization; TVR = target vessel revascularization.